The assumption is that NGIO will be merged into a company already listed. If this is the case, does an S-1, or other SEC document, need to filed?
Any other insights on how NGIO becomes public company?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
